Skip to content

ARCHITECT 7K61-37Recalls & reported problems

Abbott Ireland · ARCHITECT B12 Reagent Kit (500T) · Class 2

Adverse event reports
4
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00380740014193), received between Dec 5, 2020 and Nov 4, 2024 — classified as 4 malfunctions.

The most frequently reported specific device problem is “High Test Results” (4 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • High Test Results4

Patient problems

  • No Clinical Signs, Symptoms or Conditions3
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 4, 2024High Test Results; High Test Results

    THE CUSTOMER REPORTED DOCTORS QUESTIONING FALSELY HIGH ARCHITECT VITAMIN B12 RESULTS FOR MULTIPLE PATIENT SAMPLES. THE CUSTOMER STATED HIGH RESULTS OF > 2000 PG/ML WERE BEING GENERATED ACROSS 2 OF THEIR ANALYZERS. THE CUSTOMER SENT THE SAMPLES OUT TO ANOTHER LAB (REFERENCE LAB) AND THE B12 RESULT OF ONE SAMPLE CAME BACK AS 285 PG/ML. THE CUSTOMER¿S REFERENCE RANGE FOR B12 IS 213-816 PG/ML. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20600937 ↗
  • MalfunctionJun 14, 2023High Test Results; High Test Results

    THE CUSTOMER REPORTED FALSELY ELEVATED ARCHITECT B12 RESULT FOR ONE PATIENT WHEN RUNNING ON THE ARCHITECT I2000SR ANALYZER. THE FOLLOWING DATA WAS PROVIDED: SID (B)(6): INITIAL B12 RESULT = 480 PG/ML; REPEAT B12 RESULTS = 265 AND 256 PG/ML THE CUSTOMER'S PROCEDURE IS TO REPEAT SAMPLES W/ RESULTS > 315 PG/ML (NORMAL REFERENCE RANGE IS 300-2000 PG/ML). THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17132158 ↗
  • MalfunctionJan 6, 2022High Test Results; High Test Results

    THE CUSTOMER REPORTED A FALSELY ELEVATED ARCHITECT B12 RESULT ON A PATIENT. RESULTS PROVIDED: (B)(6) 2021, SID (B)(6)= 364 PG/ML< REPEATED ON (B)(6) 2021 = 274 PG/ML (BOTH RESULTS USING LOT# 23108UI00). NORMAL RANGE: 345-1485 PG/ML. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13176978 ↗
  • MalfunctionDec 5, 2020High Test Results; High Test Results

    THE CUSTOMER OBSERVED A FALSELY ELEVATED ARCHITECT B12 RESULT FOR ONE PATIENT. THE FOLLOWING DATA WAS PROVIDED (CUSTOMER¿S REFERENCE RANGE IS 211-911 PG/ML): PATIENT # INITIAL RESULT, ON (B)(6) 2020, WAS 240, REPEATS WERE 197 AND 160 PG/ML. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 10951364 ↗

Other RADIOASSAY, VITAMIN B12 devices

All RADIOASSAY, VITAMIN B12 devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.